Correlation of low numbers of intratumoral FOXP3+ cells with worse progression-free survival in angioimmunoblastic T cell lymphoma.
J Clin Pathol. 2023 Aug 24:jcp-2023-208932. doi: 10.1136/jcp-2023-208932. Online ahead of print.PMID: 37620127
Combination of Sarcopenia and Anemia Predicts Worse Outcome in
Elderly Patients With Diffuse Large B-Cell Lymphoma.
In Vivo. 2023 Jul-Aug;37(4):1847-1856. doi: 10.21873/invivo.13276.PMID: 37369473Free PMC article.
Mutation-Driven S100A8 Overexpression Confers Aberrant Phenotypes in Type 1 CALR-Mutated MPN.
Int J Mol Sci. 2023 May 14;24(10):8747. doi: 10.3390/ijms24108747.PMID: 37240094Free PMC article.
Children with chronic myeloid leukaemia treated with front-line imatinib have a slower molecular response and comparable survival compared with adults: a multicenter experience in Taiwan.
Br J Cancer. 2023 Mar;128(7):1294-1300. doi: 10.1038/s41416-023-02162-9. Epub 2023 Jan 30.PMID: 36717672
Flow Cytometry Analysis Reveals a Wide Cytologic and Immunophenotypic Spectrum of Peripheral B Lymphocytes in Angioimmunoblastic T-Cell Lymphoma.
Pathobiology. 2023;90(3):187-198. doi: 10.1159/000526284. Epub 2022 Nov 24.PMID: 36423589
Oral Chemotherapy Application in Elderly Patients With Diffuse Large B-Cell Lymphoma: An Alternative Regimen in Retrospective Analysis.
J Hematol. 2022 Oct;11(5):176-184. doi: 10.14740/jh1054. Epub 2022 Oct 31.PMID: 36406829Free PMC article.
Comparison of molecular responses and outcomes between BCR::ABL1 e14a2 and e13a2 transcripts in chronic myeloid leukemia.
Cancer Sci. 2022 Oct;113(10):3518-3527. doi: 10.1111/cas.15501. Epub 2022 Aug 17.PMID: 35869805Free PMC article.
Isatuximab-Pomalidomide-Dexamethasone Versus Pomalidomide-Dexamethasone in East Asian Patients With Relapsed/Refractory Multiple Myeloma: ICARIA-MM Subgroup Analysis.
Clin Lymphoma Myeloma Leuk. 2022 Aug;22(8):e751-e761. doi: 10.1016/j.clml.2022.04.005. Epub 2022 Apr 8.PMID: 35641409
Investigation of the incidence trend of follicular lymphoma from 2008 to 2017 in Taiwan and the United States using population-based data.
PLoS One. 2022 Mar 17;17(3):e0265543. doi: 10.1371/journal.pone.0265543. eCollection 2022.PMID: 35298555Free PMC article.
The Cost-Effectiveness Analysis of Transplant-Ineligible Myeloma Patients with Bortezomib plus Thalidomide plus Dexamethasone (VTD) or Bortezomib plus Melphalan plus Prednisolone (VMP) Treatment in Southern Taiwan.
J Pers Med. 2022 Jan 19;12(2):130. doi: 10.3390/jpm12020130.PMID: 35207619Free PMC article.
Oral azacitidine preserves favorable level of fatigue and health-related quality of life for patients with acute myeloid leukemia in remission: results from the phase 3, placebo-controlled QUAZAR AML-001 trial.
Haematologica. 2021 Dec 1;106(12):3240-3244. doi: 10.3324/haematol.2021.279174.PMID: 34551506Free PMC article.Clinical Trial.No abstract available.
Role of quantitative hepatitis B surface antibodies in preventing hepatitis B virus-related hepatitis in patients treated with rituximab.
Leuk Lymphoma. 2021 Dec;62(12):2899-2906. doi: 10.1080/10428194.2021.1948034. Epub 2021 Jul 29.PMID: 34323157
Subgroup analysis of ICARIA-MM study in relapsed/refractory multiple myeloma patients with high-risk cytogenetics.
2021 Jul;194(1):120-131. doi: 10.1111/bjh.17499. Epub 2021 May 25.PMID: 34036560Free PMC article.
A comprehensive retrospective cohort study of the journey of B-cell lymphoma in Taiwan.
Sci Rep. 2021 May 12;11(1):10069. doi: 10.1038/s41598-021-89316-y.PMID: 33980914Free PMC article.
Differential impacts of hemolysis on coagulation parameters of blood samples: A STROBE-compliant article.
Medicine (Baltimore). 2021 May 7;100(18):e25798. doi: 10.1097/MD.0000000000025798.PMID: 33950978Free PMC article.
Copanlisib plus rituximab versus placebo plus rituximab in patients with relapsed indolent non-Hodgkin lymphoma (CHRONOS-3): a double-blind, randomised, placebo-controlled, phase 3 trial.
Lancet Oncol. 2021 May;22(5):678-689. doi: 10.1016/S1470-2045(21)00145-5. Epub 2021 Apr 10.PMID: 33848462Clinical Trial.
The status of jaw lesions and medication-related osteonecrosis of jaw in patients with multiple myeloma.
J Formos Med Assoc. 2021 Nov;120(11):1967-1976. doi: 10.1016/j.jfma.2021.01.015. Epub 2021 Feb 4.PMID: 33551311
Analysis of latent T-cell epitopes in Epstein-Barr virus isolated from extranodal nasal-type natural killer/T-cell lymphoma in Taiwanese population.
Exp Mol Pathol. 2021 Feb;118:104577. doi: 10.1016/j.yexmp.2020.104577. Epub 2020 Nov 23.PMID: 33242451
Inotuzumab ozogamicin versus standard of care in Asian patients with relapsed/refractory acute lymphoblastic leukemia.
Int J Hematol. 2019 Dec;110(6):709-722. doi: 10.1007/s12185-019-02749-0. Epub 2019 Nov 13.PMID: 31655984Clinical Trial.
Molecular heterogeneity unravelled by single-cell transcriptomics in patients with essential thrombocythaemia.
Br J Haematol. 2020 Mar;188(5):707-722. doi: 10.1111/bjh.16225. Epub 2019 Oct 14.PMID: 31610612Clinical Trial.
RHOA G17V mutation in angioimmunoblastic T-cell lymphoma: A potential biomarker for cytological assessment.
Exp Mol Pathol. 2019 Oct;110:104294. doi: 10.1016/j.yexmp.2019.104294. Epub 2019 Aug 5.PMID: 31394087
Recurrent monomorphic epitheliotropic intestinal T-cell lymphoma with aberrant CD20 expression: An implication for anti-CD20 (rituximab) antibody therapy?
Pathol Int. 2018 Dec;68(12):712-714. doi: 10.1111/pin.12730. Epub 2018 Nov 6.PMID: 30402988No abstract available.
Impacts of demographic and laboratory parameters on key hematological indices in an adult population of southern Taiwan: A cohort study.
PLoS One. 2018 Aug 2;13(8):e0201708. doi: 10.1371/journal.pone.0201708. eCollection 2018.PMID: 30071080Free PMC article.
TP53 mutations in peripheral mature T and NK cell lymphomas: a whole-exome sequencing study with correlation to p53 expression.
Hum Pathol. 2018 Oct;80:145-151. doi: 10.1016/j.humpath.2018.05.026. Epub 2018 Jun 6.PMID: 29885407
A Newly Recognized Histologic Pattern of IgG4-related Lymphadenopathy: Expanding the Morphologic Spectrum.
Am J Surg Pathol. 2018 Jul;42(7):977-982. doi: 10.1097/PAS.0000000000001076.PMID: 29738364
A Phase II Study of Arginine Deiminase (ADI-PEG20) in Relapsed/Refractory or Poor-Risk Acute Myeloid Leukemia Patients.
Sci Rep. 2017 Sep 12;7(1):11253. doi: 10.1038/s41598-017-10542-4.PMID: 28900115Free PMC article.Clinical Trial.
A noninterventional observational registry of patients with multiple myeloma treated with lenalidomide in Taiwan.
J Formos Med Assoc. 2017 Sep;116(9):705-710. doi: 10.1016/j.jfma.2016.11.005. Epub 2016 Dec 21.PMID: 28012677
Characteristics of Taiwanese patients of PNH in the international PNH registry.
Thromb J. 2016 Oct 4;14(Suppl 1):39. doi: 10.1186/s12959-016-0094-0. eCollection 2016.PMID: 27766064Free PMC article.
Nontuberculous mycobacterial infection with concurrent IgG4-related lymphadenopathy.
APMIS. 2016 Mar;124(3):216-20. doi: 10.1111/apm.12492. Epub 2015 Dec 14.PMID: 26660641
Eltrombopag enhances platelet adhesion by upregulating the expression of glycoprotein VI in patients with chronic immune thrombocytopenic purpura.
Transl Res. 2015 Dec;166(6):750-761.e4. doi: 10.1016/j.trsl.2015.09.005. Epub 2015 Sep 30.PMID: 26477577
Genetic disposition and modifiable factors independently associated with anemia in patients with type 2 diabetes mellitus.
Diabetes Res Clin Pract. 2015 Apr;108(1):164-9. doi: 10.1016/j.diabres.2014.12.012. Epub 2015 Jan 21.PMID: 25656761
Efficacy and safety of ruxolitinib in Asian patients with myelofibrosis.
Leuk Lymphoma. 2015 Jul;56(7):2067-74. doi: 10.3109/10428194.2014.969260. Epub 2014 Nov 20.PMID: 25315076Clinical Trial.
Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial.
Lancet Oncol. 2014 Oct;15(11):1195-206. doi: 10.1016/S1470-2045(14)70440-1. Epub 2014 Sep 18.PMID: 25242045Clinical Trial.
Pharmacokinetic profile and first preliminary clinical evaluation of bendamustine in Taiwanese patients with heavily pretreated indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma.
Hematol Oncol. 2015 Dec;33(4):136-44. doi: 10.1002/hon.2161. Epub 2014 Aug 11.PMID: 25111959Clinical Trial.
Spectrum of Epstein-Barr virus-associated T-cell lymphoproliferative disorder in adolescents and young adults in Taiwan.
Int J Clin Exp Pathol. 2014 Apr 15;7(5):2430-7. eCollection 2014.PMID: 24966953Free PMC article.
TMPRSS6 rs855791 polymorphism influences the susceptibility to iron deficiency anemia in women at reproductive age.
Int J Med Sci. 2014 Apr 16;11(6):614-9. doi: 10.7150/ijms.8582. eCollection 2014.PMID: 24782651Free PMC article.
Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: a prospective study.
Hepatology. 2014 Jun;59(6):2092-100. doi: 10.1002/hep.26718. Epub 2014 Apr 14.PMID: 24002804
Infectious mononucleosis mimicking malignant T-cell lymphoma in the nasopharynx: a case report and review of the literature.
Int J Clin Exp Pathol. 2013;6(1):105-9. Epub 2012 Nov 20.PMID: 23236550Free PMC article.Review.
Emerging kinetics of BCR-ABL1 mutations and their effect on disease outcomes in chronic myeloid leukemia patients with imatinib failure.
Leuk Res. 2013 Jan;37(1):43-9. doi: 10.1016/j.leukres.2012.09.012. Epub 2012 Oct 9.PMID: 23062378
Lee C-H, Wang M-C, Huang I-W, Chen F-J, Lauderdale T-L*. Development of Daptomycin Nonsusceptibility with Heterogeneous Vancomycin-Intermediate Resistance and Oxacillin Susceptibility in Methicillin-Resistant Staphylococcus aureus during High-Dose Daptomycin Treatment. Antimicrob Agents Chemother. 2010; 54(9):4038-40.(SCI;IF=4.672; Pharmacology & pharmacy 21/216)
Chen J-Y, Wang M-C, Hung W-C*. Bcr-Abl-induced tyrosine phosphorylation of Emi1 to stabilize Skp2 protein via inhibition of ubiquitination in chronic myeloid leukemia cells. Journal of Cellular Physiology. 2011; 226(2):407-13. (SCI IF=3.874; Phsyiology 12/79)
Liang C-M, Wang M-C, Chen Y-J, Hung C-H*, Hu T-H. Primary Duodenal Mucosa-Associated Lymphoid Tissue Lymphoma: Report of a Case. Gastroenterol J Taiwan 2011;28:40-6
Wang M-C , Yang K-T, Chen J-Y, Hsu M-C, Hung W-C*. Bcr-Abl oncogene stimulates jab1 expression via cooperative interaction of β-catenin and STAT1 in chronic myeloid leukemia cells. Journal of Cellular Physiology 2011;226:2849-56 (first author, Yang K-T, Wang M-C, Chen J-Y contributed equally to this work) (SCI;IF=3.874; Physiology 12/79)
Pei SN, Ma MC, Wang MC, Kuo CY, Rau KM, Su CY, Chen CH*. Analysis of hepatitis B surface antibody titers in B cell lymphoma patients after rituximab therapy. Ann Hematol. 2012 Jul;91(7):1007-12 (SCI;IF=2.688; Hematology 33/65)
